Personal Products
Emami Limited manufactures and markets personal and healthcare products in India and internationally. It provides ayurvedic antiseptic cream, prickly heat powder, doodh kesar body lotion, aloe neem lotion, vasocare herbal petroleum jelly, coconut oil, aloe vera gel, and hygiene products under the Boroplus brand; cool oil, extra thanda, gold ayurvedic oil, therapy ayurvedic body massage and stress relief oil, maxx cool talc, and cool talc under the Navratna brand; and balm, balm ultra-power, quick relief roll-on, ortho vedic oil, ointment, relief gel and spray, healthcare products, pancharishta, nityam, and kesari jivan under the Zandu brand. The company also offers radiance cream and instant radiance face wash for men under the Fair and Handsome brand; haircare products and shampoo under the Kesh King brand; balm under the Mentho Plus brand; prickly heat powder under the Dermicool brand; hair oil, shampoos, and conditioners under the Emami 7 Oils in One brand; deodorants under the HE brand; hair colors under the Emami Diamond Shine brand; talc under the Emami Golden Beauty brand; herbal fairness cream under the Emami Naturally Fair brand; toothpaste under the Ayucare brand; hair colors and oils under the Emami Gold brand; and moisturisers, lotion, soft creams, glycerine creams and oils, petroleum jelly, baby shampoos, and other skin products under the Cream21 brand. Emami Limited was founded in 1974 and is headquartered in Kolkata, India.
Profitability: Very strong Profitability. One year profit margin are 21%.
Size: Market Cap wise it is among the top 20% companies of india.
Smart Money: Smart money has been increasing their position in the stock.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Balance Sheet: Strong Balance Sheet.
Technicals: SharesGuru indicator is Bearish.
Momentum: Stock is suffering a negative price momentum. Stock is down -10.8% in last 30 days.
Comprehensive comparison against sector averages
EMAMILTD metrics compared to Personal
Category | EMAMILTD | Personal |
---|---|---|
PE | 31.71 | 52.97 |
PS | 6.58 | 7.97 |
Growth | 6.2 % | 3.4 % |
EMAMILTD vs Personal (2021 - 2025)
Understand Emami ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
Shareholder Name | Holding % |
---|---|
SURAJ FINVEST PRIVATE LIMITED | 24.22% |
DIWAKAR FINVEST PRIVATE LIMITED | 22.6% |
DSP AGGRESSIVE HYBRID FUND | 3.77% |
PRITI A SUREKA | 3.46% |
KOTAK EMERGING EQUITY SCHEME | 3.37% |
HDFC LARGE AND MID CAP FUND | 3.16% |
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA ETF NIFTY MIDCAP 150 | 3.15% |
AVEES TRADING AND FINANCE PVT LTD | 2% |
FRANKLIN INDIA MULTI CAP FUND | 1.75% |
SBI LARGE & MIDCAP FUND | 1.73% |
UTI AGGRESSIVE HYBRID FUND | 1.4% |
PINEBRIDGE GLOBAL FUNDS - PINEBRIDGE INDIA EQUITY FUND | 1.06% |
PAN EMAMI COSMED LIMITED | 0.71% |
AVISHI SUREKA | 0.32% |
EMAMI PAPER MILLS LTD | 0.21% |
SACHIN GOENKA | 0.16% |
SHOBHANA AGARWAL | 0.14% |
ADVAY GOENKA | 0.13% |
MANAN GOENKA | 0.13% |
DARSH GOENKA | 0.13% |
Distribution across major stakeholders
Distribution across major institutional holders
Summary of Emami's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
Last updated: May 25
In the earnings call for Q4 and FY '25, Emami Limited's management expressed optimism for the upcoming financial year, citing strong growth potential driven by several strategic initiatives. Key points from the management's outlook include:
Strong Domestic Business Growth: The company's core domestic business achieved a robust 11% growth in Q4, with a 7% volume increase across various brands. Notable performances included BoroPlus with a 27% increase and Navratna with a 16% rise.
International Recovery: The international business grew by 6% in Q4, rebounding from prior declines. This growth was attributed to strong performances in regions like SAARC, Southeast Asia, and CIS, despite challenges in Bangladesh and parts of Africa.
Consolidated Financial Performance: Q4 consolidated revenue reached Rs. 963 crores (+8%). For FY '25, consolidated revenue was Rs. 3,809 crores (+6.5%), with EBITDA growth of 8% to Rs. 1,025 crores.
Dividend Announcement: The Board approved a special interim dividend of 200%, bringing the total dividend payout for FY '25 to Rs. 10 per share.
Expectations for FY '26: The management anticipates sustained market share growth and household penetration, with expectations of a gradual consumption recovery bolstered by easing inflation and government spending. They forecast continued momentum in male grooming segments, particularly with planned enhancements for brands like Kesh King and The Man Company, aiming for high double-digit growth.
Innovation and Product Development: Emami has launched over 25 new products in FY '25, focusing on D2C strategies through their Zanducare portal. They project that products launched in the past two years will account for around 50% of Zanducare's total sales.
Overall, the management's outlook is characterized by a positive trajectory in growth across domestic and international sectors, supported by a strong product pipeline and strategic initiatives aimed at addressing previous challenges in specific brands.
Last updated: May 25
Here are the major questions and their respective answers from the earnings transcript of Emami Limited's Q4 FY '25 earnings conference call:
Question 1: "What will be Zairus Master's key KRA for the next two to three years at The Man Company?"
Answer: "We are excited to have Zairus on board. His main targets are to achieve substantial growth for The Man Company and reach profitability for our brands in the long term. While I don't expect immediate profits, turning the business around is a priority."
Question 2: "How do you foresee the summer product performance given the rain and tough comparables?"
Answer: "You've raised a valid point. Q1 is indeed challenging due to an unfavorable base and weather conditions affecting our summer portfolio. We hope to see some rebound in the coming weeks, but it will be tough to match last year's performance."
Question 3: "Did BoroPlus experience any peculiar growth in Q4?"
Answer: "BoroPlus performs well in unfavorable summer weather. Given the lower temperatures and tougher conditions, it outperformed our summer products. It's largely seasonal growth and we expect it to continue in the first quarter too."
Question 4: "What is your revenue expectation for TMC and Brillare for FY '26?"
Answer: "For FY '26, we anticipate high double-digit growth for both The Man Company and Brillare. We're making substantial investments to enhance their brand franchise and are already seeing early signs of growth."
Question 5: "What is your outlook on the pain management category which has shown slow growth?"
Answer: "Pain management is crucial, contributing about 20% to our revenue. While Zandu balm shows stress, we've got new products lined up to boost growth, including two new launches in FY '26. We believe innovations will revive this segment."
Question 6: "What pricing growth should we expect in FY '26?"
Answer: "We expect pricing growth of around 2% to 3% in FY '26, consistent with recent trends."
Question 7: "What was the consumer response to the Smart and Handsome rebranding?"
Answer: "The rebranding has led to some positive momentum after a prolonged decline. We anticipate continued growth. The focus is on expanding into male grooming products and creating a robust marketing strategy."
Question 8: "What are the contributions from new products launched in FY '25 and the target for FY '26?"
Answer: "New products contributed around 4% of our revenue in FY '25. For FY '26, we target a similar contribution around 3%, depending on market reception of new launches."
Valuation | |
---|---|
Market Cap | 24.78 kCr |
Price/Earnings (Trailing) | 31.47 |
Price/Sales (Trailing) | 6.53 |
EV/EBITDA | 23.06 |
Price/Free Cashflow | 39.6 |
MarketCap/EBT | 28.08 |
Fundamentals | |
---|---|
Revenue (TTM) | 3.8 kCr |
Rev. Growth (Yr) | 5.07% |
Rev. Growth (Qtr) | 16.69% |
Earnings (TTM) | 787.32 Cr |
Earnings Growth (Yr) | 7.03% |
Earnings Growth (Qtr) | 32.22% |
Profitability | |
---|---|
Operating Margin | 23.25% |
EBT Margin | 23.25% |
Return on Equity | 29.97% |
Return on Assets | 21.91% |
Free Cashflow Yield | 2.53% |
Investor Care | |
---|---|
Dividend Yield | 1.76% |
Dividend/Share (TTM) | 10 |
Shares Dilution (1Y) | 0.00% |
Diluted EPS (TTM) | 18.17 |
Financial Health | |
---|---|
Current Ratio | 1.96 |
Debt/Equity | 0.02 |
Debt/Cashflow | 11.86 |
Detailed comparison of Emami against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|---|
HINDUNILVR | Hindustan UnileverDiversified FMCG | 5.45 LCr | 64.14 kCr | -2.22% | -6.10% | 51.06 | 8.5 | +2.28% | +3.78% |
ITC | ITCDiversified FMCG | 5.22 LCr | 84.7 kCr | -4.28% | -3.27% | 25.54 | 6.16 | +7.07% | -1.77% |
GODREJCP | Godrej Consumer ProductsPersonal Care | 1.22 LCr | 14.68 kCr | -8.16% | -14.32% | 65.92 | 8.31 | +2.22% | +430.42% |
DABUR | Dabur IndiaPersonal Care | 82.68 kCr | 13.09 kCr | -1.09% | -22.54% | 46.74 | 6.32 | +2.70% | +0.34% |
MARICO | MaricoEdible Oil | 88.9 kCr | 11.04 kCr | -5.27% | - | 53.62 | 8.05 | +12.70% | +10.39% |